GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ABION Inc (XKRX:203400) » Definitions » Float Percentage Of Total Shares Outstanding

ABION (XKRX:203400) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 28, 2025)


View and export this data going back to 2014. Start your Free Trial

What is ABION Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, ABION's float shares is 0.00 Mil. ABION's total shares outstanding is 28.64 Mil. ABION's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, ABION's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, ABION's Institutional Ownership is 0.02%.


ABION Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

ABION's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/28.64
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ABION Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ABION Inc (XKRX:203400) » Definitions » Float Percentage Of Total Shares Outstanding
Traded in Other Exchanges
N/A
Address
9th FI, HanWha Biz Metro Building, 242 Digital-ro, Guro-gu, Seoul, KOR, 08394
ABION Inc is a biopharmaceutical company. It is primarily involved in the research and development new bio pharmaceutical drugs and companion diagnostics systems for the treatment of incurable diseases.

ABION Headlines

No Headlines